I can really see anything that could not have been released in late Oct. I think the traders will have a good day today as the information released isn't earth shattering and not what we had been told was coming.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress